Medizone International Inc (OTCMKTS:MZEI) shares were flat on Tuesday and unchanged in after-hours trading. Share prices have been trading in a 52-week range of $0.04 to $0.17. The company has a market cap of $27.86 million at 397.93 million shares outstanding.
In a press release, Medizone International Inc announced the appointment of Steve Meyer to the Board of Directors to support its expansion of the commercial experience of the team and to accelerate the growth of AsepticSure in key markets all over the world.
“We continue to look for talented executives with significant commercial experience to help guide Medizone International Inc as we work to deliver on our growth plans and reach our full potential in the market,” commented David A. Esposito, Chairman of the Board and interim CEO of Medizone International.
“As we execute on our commercial plans to establish the AsepticSure system as the new gold standard for disinfection across a wide range of commercial applications, we are pleased to announce that Steve Meyer has joined our Board of Directors. Steve brings a wealth of commercial experience and proven strong leadership to our team,” he continued.
Medizone International Inc also announced the appointment f bioterrorism expert Brad Goble to lead the company’s efforts to engage with government agencies and organizations tasked with coordinating global resources. He is tasked with advancing AsepticSure as a key component of programs in support of bioterrorism countermeasures and public health preparedness.
Medizone International Inc is a company that is engaged in designing, manufacturing and selling a system using ozone in the disinfection of surgical and other medical treatment facilities and in other applications. Its AsepticSure is an ozone-based technology, which is used for the purpose of decontaminating and disinfecting hospital surgical suites, emergency rooms, intensive care units and other enclosed spaces, such as gym locker rooms, laboratories and veterinary clinics. In the AsepticSure system, oxygen atoms are misted into the environment with a hydrogen peroxide vapor and the system’s formula creates Trioxidane.
The company is also developing a variant of AsepticSure for governmental use with bio-terrorism countermeasures. AsepticSure has completed safety and preliminary operational trials. During the tests, AsepticSure has demonstrated a turnaround time of approximately 90 minutes for disinfection and reoccupation of the hospital rooms.